Asthma/COPD Deck 2 Flashcards

1
Q

Cromolyn Class

A

mast cell stabalizer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cromolyn is for

A

prevention, inhaled, prevention. Not quickl relief!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cromolyn MOA

A

Stabilizes cytoplasmic membrane of mast
cells, thereby preventing release of histamine and
other mediators; in addition, inhibits eosinophils,
macrophages, and other inflammatory cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cromolyn uses and route

A

Route: nebulizer
• Uses: chronic asthma, exercise-induced
bronchospasm (EIB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cromolyn AE

A

cough or bronchospasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Omalizumab [Xolair] MOA

A

– Antagonism of immunoglobulin E (IgE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Omalizumab [Xolair] USE

A

– Patients age 12 years or older with moderate to
severe asthma that (1) is allergy related and (2)
cannot be controlled with an inhaled glucocorticoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Omalizumab [Xolair] ADR

A

injection-site reactions, viral infection, URI,

sinusitis, HA, pharyngitis, CV events, malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Omalizumab [Xolair] Black Box

A
  • life-threatening anaphylaxis
    (most likely with first dose, period of observation in
    office).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Omalizumab [Xolair] is used in a

A

allergists office

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bronchodilators use

A
Symptomatic relief, do not alter underlying
disease process (inflammation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Beta 2 agonist MOA

A

• Through activation of beta2 receptors in the smooth
muscle of the lung, these drugs promote
bronchodilation, relieving bronchospasm

• Beta2 agonists have a limited role in suppressing
histamine release in the lung and increasing ciliary
motility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SABA take

A

PRN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Exercize endused take SABA

A

before exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SABA ADR

A

– tachycardia, angina, tremor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inhaled long-acting beta2-agonists (LABA) when are they given

A

Long-term control in patients who experience frequent attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

LABA dosing is

A

is on a fixed schedule, not PRN

18
Q

LABA effective in treating

A

COPD

19
Q

LABA when used to treat asthma must always be combined with

A

glucocorticoid

20
Q

Use of what alone in asthma is contraindicated

A

LABA

21
Q

LABA ADR

A

tachycardia, agina, tremor

22
Q

LABA black box warning

A

risk for asthma-related deaths.

– Salmeterol [Serevent Diskus], formoterol [Foradil Aerolizer], and arformoterol [Brovana)

23
Q

Vilanterol – available in

A

combination – flucticasone/vilanterol

[Breo Ellipta] and umeclidinium/vilanterol [Anoro Ellipta]

24
Q

Rule of Two (5 items) Should know this for the exam

A

• No symptoms more than twice per
week.
• Should not use a short-acting beta agonist no more than twice per week.
• No interference with normal activity.
• No more than one to two flare-up in the
past year.
• Peak flow levels should be higher than

80% of the predicted or personal bests.

25
Q

Theophylline produces

A

brochodialtion by relaxing smooth muscle from the bronki

26
Q

Theophylline has a

A

narrow therapeutic indix

27
Q

Theophylline plasma levels should be between

A

10 to 20 mcg

28
Q

Theophylline Toxcicity is related to

A

levels

29
Q

Theophylline the drug is usually

A

administered by mouth, but may be given IV

30
Q

Theophylline is uesed for

A

maintenic therapy of chronic stable asthma

31
Q

Theophylline plasma levels below 20 mcg

A

adverse effects uncommon

32
Q

Theophylline plasma 20 to 25 mcg

A

n/v diarrhea, insomnia, restless ness

33
Q

Theophylline plasma above 30 mcg

A

severe dysrhymias and convulions

death may occr from cardio respiroarty collapse

34
Q

Theophylline no (methylxanthines) no longer recommended for

A

COPD

35
Q

Theophylline toxicity treatment

A

– Stop theophylline
– Activated charcoal together with a cathartic
– Dysrhythmias respond to lidocaine
– Intravenous diazepam may help control seizures

36
Q

Theophylline interactions

A

– Caffeine
– Tobacco and marijuana
– Cimetidine
– Fluoroquinolone antibiotics

37
Q

Anti-Cholinergics improve lung functions

A

by blocking muscarinic receptors in the bronchi

38
Q

Anti-Cholinergics approved fro only

A

COPD. Off label for asthma

39
Q

Ipratropium and tiotropium have a

A

longer duration of action

40
Q

Ipratropium action and use

A

– Administered by inhalation to relieve bronchospasm
– Therapeutic effects begin within 30 seconds, reach 50% of
maximum in 3 minutes, and persist about 6 hours

41
Q

Ipratropium ADR

A

– Dry mouth and irritation of the pharynx
– Glaucoma
– Cardiovascular events